# FUROSEMIDE

NDC: 51662-1336
Generic name: FUROSEMIDE
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20181126

FDA application: NDA018667

## Active ingredients

- FUROSEMIDE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1336"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1336
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b9af6a4-e1da-eb95-e053-2991aa0a031d